Newsweek

How Does Gene Therapy for Blindness Work?

The one-time treatment could restore eyesight to thousands of people.
A new gene therapy called Luxturna was being considered by the FDA on Thursday to treat retinal dystrophy, which can lead to blindness. If approved, it would be the first-ever gene replacement therapy.
GettyImages-175133840 Source: KAREN BLEIER/AFP/Getty Images

Updated | A Food and Drug Administration committee has voted that a gene therapy touted as a breakthrough for people with a particular genetic form of blindness is effective. A final FDA approval for the treatment, Luxturna, would be a landmark event for gene therapy and for sufferers of this inherited disorder.

Whether this is the first gene therapy to get this close to as treatments that use genes in some way. In theory, diseases could be cured or prevented by stopping one gene from being expressed, replacing a gene that causes a disease with one that doesn’t, or by taking a bad gene out and putting in a good gene.

You're reading a preview, sign up to read more.

More from Newsweek

Newsweek6 min read
Obama's Iran Nuclear Deal Was 'Disastrous,' Shah's Son Says
Reza Pahlavi, the exiled heir to the now-defunct Iranian throne, tells Newsweek that the bloody unrest in his home country can only be solved by removing the regime in Tehran.
Newsweek6 min read
How Math Can Help Prevent Outbreaks of Measles and Other Diseases
The measles vaccine is incredibly effective, yet recurrences and outbreaks abound. Samoa is currently undergoing an outbreak with thousands infected, and in 2019, the United States had the most cases reported since 1992. What can we do about it? In t
Newsweek9 min readPolitics
Trump's Finances: Will Voters Ever Know The Facts?
President Donald Trump's most jealously guarded secrets—his financial records, including tax returns—will probably remain hidden from voters until after the next election. That's just one likely consequence of the U.S. Supreme Court's red-letter deci